跳至主要内容
临床试验/CTRI/2018/08/015293
CTRI/2018/08/015293招募中4 期

A randomised controlled trial of Levosimendanversus Dobutamine in acute heart failure.

Department of PharmacologyIPGMERKOLKATA0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1)Patients having stage 3 or stage 4 AHF as per Killip classification.
  • 2)Patients of AHF with hypotension.
  • 3)Patients willing to give written informed consent.

排除标准

  • 1)Patients having high output failure.
  • 2)Patients having any type of ongoing ventricular arrhythmia.
  • 3)Patients developing heart failure following rheumatic carditis.
  • 4)Patients developing heart failure consequent to toxic myocarditis.
  • 5)Known patient of hypertrophic obstructive cardiomyopathy(HOCM).
  • 6)Pregnant or nursing women.
  • 7)History of hypersensitivity to study drugs.
  • 8)History of critical illness of other vital organs like liver, kidney or brain marrow.
  • 9)History of major psychiatric illness.
  • 10)History of alcoholism or substance abuse.

研究者

发起方
Department of PharmacologyIPGMERKOLKATA

相似试验